Middle Eastern Cancer and Oncology Journal

The “Middle Eastern Cancer and Oncology Journal (MECOJ)” is an online, peer-reviewed, open access journal that strives to push the boundaries of oncology by enhancing the understanding of cancer biology, evolving treatment methods, and effective prevention strategies. It is established in 2025 by OncoEval Pioneers Group and owned and published by Scientific Steps International Publishing Services which owns the copyright and licensing for all issues and articles in the journal. MECOJ serves as a critical platform for the swift publication of pioneering research that connects the intricate scientific findings with tangible clinical applications. The journal champions the exploration of innovative therapeutic approaches and groundbreaking genetic discoveries that redefine cancer care standards globally. Emphasizing both regional challenges in the Middle East and global advancements, the journal aims to foster collaborative insights that enhance cancer research and treatment outcomes worldwide.

The “Middle Eastern Cancer and Oncology Journal (MECOJ)” is published quarterly, providing a platform for the timely dissemination of high-quality research in the field of oncology. The journal publishes different types of articles in English, including original research articles, case reports, and review articles across all areas of oncology. This frequency allows for thorough peer review and ensures that each issue meets the journal’s standards for academic excellence. The peer-review process is designed to be efficient yet rigorous, typically taking between 30 to 60 days from submission to decision. As the journal grows and gains traction, we may consider increasing the frequency of publication based on the volume of high-quality submissions received.

The MECOJ is recognized by the Iraqi Society of Clinical Oncology (ISCO) as a co-publisher.